HuGE Literature Finder
Records
1
-
30
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. BMC medical genomics 2022 Jun 15 (1): 141. Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X |
| Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab. JAMA network open 2022 Jun 5 (6): e2215589. Liu Yufei, Zhang Zhe, Rinsurongkawong Waree, Gay Carl M, Le Xiuning, Ning Matthew S, Lewis Jeff, Rinsurongkawong Vadeerat, Lee J Jack, Roth Jack, Swisher Stephen, Gandhi Saumil, Lee Percy P, Gibbons Don L, Vaporciyan Ara A, Heymach John V, Zhang Jianjun, Lin Steven |
| Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer. European journal of cancer (Oxford, England : 1990) 2022 Jun 172 85-95. Rosellini Pietro, Amintas Samuel, Caumont Charline, Veillon Rémi, Galland-Girodet Sigolène, Cuguillière Alain, Nguyen Laurent, Domblides Charlotte, Gouverneur Amandine, Merlio Jean-Philippe, Bezin Julien, Girodet Pierre-Olivi |
| Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022 Jun . Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam |
| An individual nomogram can reliably predict tumor spread through air spaces in non-small-cell lung cancer. BMC pulmonary medicine 2022 May 22 (1): 209. Wang Shuai, Shou Huankai, Wen Haoyu, Wang Xingxing, Wang Haixing, Lu Chunlai, Gu Jie, Xu Fengkai, Zhu Qiaoliang, Wang Lin, Ge |
| Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases. The oncologist 2022 May . Huang Richard S P, Harries Lukas, Decker Brennan, Hiemenz Matthew C, Murugesan Karthikeyan, Creeden James, Tolba Khaled, Stabile Laura P, Ramkissoon Shakti H, Burns Timothy F, Ross Jeffrey |
| Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome. Lung cancer (Amsterdam, Netherlands) 2022 May 169 31-39. Mogenet Alice, Barlesi Fabrice, Besse Benjamin, Michiels Stefan, Karimi Maryam, Tran-Dien Alicia, Girard Nicolas, Mazieres Julien, Audigier-Valette Clarisse, Locatelli-Sanchez Myriam, Kamal Maud, Gestraud Pierre, Hamza Abderaouf, Jacquet Alexandra, Jimenez Marta, Yara Sabrina, Greillier Laurent, Bertucci François, Planchard David, Soria Jean-Charles, Bieche Ivan, Tomasini Pasca |
| Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients. Cancers 2022 May 14 (10): . Ulivi Paola, Urbini Milena, Petracci Elisabetta, Canale Matteo, Dubini Alessandra, Bartolini Daniela, Calistri Daniele, Cravero Paola, Fonzi Eugenio, Martinelli Giovanni, Priano Ilaria, Andrikou Kalliopi, Bronte Giuseppe, Crinò Lucio, Delmonte Ange |
| Impact of genetic status on the survival outcomes of patients with clinical stage I non-small cell lung cancer with a radiological pure-solid appearance. Lung cancer (Amsterdam, Netherlands) 2022 Feb 166 63-69. Sun Ke, Li Meiling, Shang Mingdong, Su Xiaolian, Zhao Jiabi, Wang Bin, Wu Chunyan, Zhang Lei, Yang Shan, Sun Xiw |
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma. Pathology, research and practice 2022 Jan 231 153761. Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu |
| Loss of STING expression is prognostic in non-small cell lung cancer. Journal of surgical oncology 2022 Jan . Lohinai Zoltan, Dora David, Caldwell Charles, Rivard Christopher J, Suda Kenichi, Yu Hui, Rivalland Gareth, Ellison Kim, Rozeboom Leslie, Dziadziuszko Rafal, Mitchell Paul, John Thomas, Millan Inigo S, Ren Shengxiang, Hirsch Fred |
| Detection and Significance of Cell-Free DNA Mutation in Pleural Effusion in Patients with Advanced NSCLC. Emergency medicine international 2022 2022 3112281. Qiao Man, Li Dongsheng, He Yuan, Zhang Cen, Chi Hang, Li Xiaoqiu, Cui QingMing, Li ShaoYing, Jiao Ying, Wei Yu |
| Prevalence of targeted therapy-related genetic variations in NSCLC and their relationship with clinicopathological characteristics. PloS one 2022 17 (1): e0262822. Li Fanghua, Ye Peng, Cai Peiling, Dong Dandan, Zhang Yihao, Yang Yue, Sun Xingwa |
| Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer. European journal of cancer (Oxford, England : 1990) 2021 Nov . Peralta-Arrieta Irlanda, Trejo-Villegas Octavio A, Armas-López Leonel, Ceja-Rangel Hugo A, Ordóñez-Luna María Del Carmen, Pineda-Villegas Priscila, González-López Marco A, Ortiz-Quintero Blanca, Mendoza-Milla Criselda, Zatarain-Barrón Zyanya L, Arrieta Oscar, Zúñiga Joaquín, Ávila-Moreno Federi |
| Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases. Pathobiology : journal of immunopathology, molecular and cellular biology 2021 Nov 1-6. De Marchi Pedro, Berardinelli Gustavo Noriz, Cavagna Rodrigo de Oliveira, Pinto Icaro Alves, da Silva Flavio Augusto Ferreira, Duval da Silva Vinicius, Santana Iara Viana Vidigal, da Silva Eduardo Caetano Albino, Ferro Leal Leticia, Reis Rui Manu |
| Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutations. European journal of cancer (Oxford, England : 1990) 2021 Nov 159 227-236. Vassella Erik, Kashani Elham, Zens Philipp, Kündig Alexandra, Fung Christian, Scherz Amina, Herrmann Evelyn, Ermis Ekin, Schmid Ralph A, Berezowska Sabi |
| p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics. Translational oncology 2021 Nov 15 (1): 101276. Ruiz-Patiño Alejandro, Rodríguez July, Cardona Andrés F, Ávila Jenny, Archila Pilar, Carranza Hernán, Vargas Carlos, Otero Jorge, Arrieta Oscar, Zatarain-Barrón Lucia, Sotelo Carolina, Ordoñez Camila, García-Robledo Juan Esteban, Rojas Leonardo, Bermúdez Maritza, Gámez Tatiana, Mayorga Diana, Corrales Luis, Martín Claudio, Recondo Gonzalo, Mas Luis, Samtani Suraj, Ricaurte Luisa, Malapelle Umberto, Russo Alessandro, Barrón Feliciano, Santoyo Nicolas, Rolfo Christian, Rosell Rafael, , |
| Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib. Lung cancer (Amsterdam, Netherlands) 2021 Oct . Bauml Joshua M, Li Bob T, Velcheti Vamsidhar, Govindan Ramaswamy, Curioni-Fontecedro Alessandra, Dooms Christophe, Takahashi Toshiaki, Duda Andrew W, Odegaard Justin I, Cruz-Guilloty Fernando, Jin Liming, Zhang Ying, Anderson Abraham, Skoulidis Ferdinand |
| Predictive value of EGFR mutation in NSCLC patients treated with platinum doublet postoperative chemotherapy. Cancer science 2021 Oct . Takahashi Toshiaki, Sakai Kazuko, Kenmotsu Hirotsugu, Yoh Kiyotaka, Daga Haruko, Ohira Tatsuo, Ueno Tsuyoshi, Aoki Tadashi, Hayashi Hidetoshi, Yamazaki Koji, Hosomi Yukio, Chen-Yoshikawa Toyofumi F, Okumura Norihito, Takiguchi Yuichi, Sekine Akimasa, Haruki Tomohiro, Yamamoto Hiromasa, Sato Yuki, Akamatsu Hiroaki, Seto Takashi, Saeki Sho, Sugio Kenji, Nishio Makoto, Inokawa Hidetoshi, Yamamoto Nobuyuki, Nishio Kazuto, Tsuboi Masahi |
| The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna B, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sonke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
| Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. Free radical biology & medicine 2021 Oct 177 58-71. Delgobo Marina, Gonçalves Rosângela Mayer, Delazeri Marco Antônio, Falchetti Marcelo, Zandoná Alessandro, Nascimento das Neves Raquel, Almeida Karoline, Fagundes Adriane Cristina, Gelain Daniel Pens, Fracasso João Isidro, Macêdo Guilherme Baroni de, Priori Leonardo, Bassani Nicklas, Bishop Alexander James Roy, Forcelini Cassiano Mateus, Moreira José Cláudio Fonseca, Zanotto-Filho Alf |
| Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer. Cancer treatment and research communications 2021 Sep 29 100471. Ottestad Anine Larsen, Dai Hong Yan, Halvorsen Tarje Onsøien, Emdal Elisabeth Fritzke, Wahl Sissel Gyrid Freim, Grønberg Bjørn Henni |
| Neutrophil-to-lymphocyte ratio is correlated to driver gene mutations in surgically-resected non-small cell lung cancer and its post-operative evolution impacts outcomes. Clinical lung cancer 2021 Aug . Seitlinger Joseph, Prieto Mathilde, Guerrera Francesco, Streit Arthur, Gauchotte Guillaume, Siat Joelle, Falcoz Pierre-Emmanuel, Massard Gilbert, Ferri Lorenzo, Spicer Jonathan, Renaud Stépha |
| PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort. Clinical lung cancer 2021 Aug . Jin Yan, Xue Qianqian, Shen Xuxia, Zheng Qiang, Chen Haiquan, Zhou Xiaoyan, Li Yu |
| PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study. Scientific reports 2021 Aug 11 (1): 16892. Cronin-Fenton Deirdre, Dalvi Tapashi, Movva Naimisha, Pedersen Lars, Hansen Hanh, Fryzek Jon, Hedgeman Elizabeth, Mellemgaard Anders, Rasmussen Torben R, Shire Norah, Hamilton-Dutoit Stephen, Nørgaard Met |
| Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Lung cancer (Amsterdam, Netherlands) 2021 Jul 159 128-134. Yoh Kiyotaka, Matsumoto Shingo, Furuya Naoki, Nishino Kazumi, Miyamoto Shingo, Oizumi Satoshi, Okamoto Norio, Itani Hidetoshi, Kuyama Shoichi, Nakamura Atsushi, Nishi Koichi, Fukuda Ikue, Tsuta Koji, Hayashi Yuichiro, Motoi Noriko, Ishii Genichiro, Goto Koic |
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| The Absence of Mutations in the Exon 2 KRAS Gene in Several Ethnic Groups in North Sumatra May Not the Main Factor for Lung Cancer. Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH 2021 Jun 29 (2): 108-112. Soeroso Noni Novisari, Ananda Fannie Rizki, Pradana Andika, Tarigan Setia Putra, Syahruddin Elisna, Noor Dimas Ramadhi |
| Evaluation on the Distribution of EGFR, KRAS and BRAF Genes and the Expression of PD-L1 in Different Types of Lung Cancer. International journal of general medicine 2021 14 5615-5620. Zhao Rui, Gao Shan, He Haiqi, Zhang Jia, Zhang Guangjian, Wen Xiaope |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: